From the Division of Plastic, Maxillofacial, and Oral Surgery, Duke University Medical Center; and Department of Urology, University of California, Los Angeles Health.
Plast Reconstr Surg. 2022 May 1;149(5):858e-866e. doi: 10.1097/PRS.0000000000008983. Epub 2022 Mar 2.
Mastectomy skin flap necrosis following breast reconstruction may lead to wound dehiscence, infection, implant exposure, and reconstructive failure. The absence of a standardized definition for it has led to variation in estimated incidence, from as low as 2 percent to greater than 40 percent. The authors systematically reviewed the literature on mastectomy skin flap necrosis to characterize existing definitions and provide a framework for future classification.
A systematic review of the PubMed and Cochrane databases identified studies reporting a discrete definition of mastectomy skin flap necrosis and corresponding outcomes in breast reconstruction. Provided definitions were extracted, categorized, and comparatively analyzed.
Fifty-nine studies met inclusion criteria, with a combined total of 14,368 patients and 18,920 breasts. Thirty-four studies (57.6 percent) reported mastectomy skin flap necrosis solely as a function of total breasts, and 11 (18.6 percent) reported mastectomy skin flap necrosis solely as a function of total patients. Only 14 studies (23.7 percent) provided two separate rates. The overall rate of mastectomy skin flap necrosis was 10.4 percent (range, 2.3 to 41.2 percent) and 15.3 percent (range, 4.7 to 39.0 percent), when reported per breast or per patient, respectively. Studies were categorized by mastectomy skin flap necrosis definition, including intervention (n = 33), depth (n = 20), area (n = 4), and timing (n = 2). Mastectomy skin flap necrosis rates were highest in studies defining necrosis by depth (15.1 percent), followed by intervention (9.6 percent), timing (6.4 percent), and area (6.3 percent). Necrosis rates among studies defining mastectomy skin flap necrosis by intervention, depth, and area were found to be statistically different (p < 0.001).
Reported mastectomy skin flap necrosis definitions and outcomes vary significantly in the existing literature. For accurate characterization and quantification, a clear, simplified, consensus definition must be adopted.
乳房重建术后乳房皮瓣坏死可导致伤口裂开、感染、植入物暴露和重建失败。由于缺乏标准化的定义,其估计发生率差异很大,低至 2%,高至 40%以上。作者系统地回顾了乳房皮瓣坏死的文献,以描述现有的定义,并为未来的分类提供框架。
对 PubMed 和 Cochrane 数据库进行系统检索,确定了报告乳房重建中明确皮瓣坏死定义和相应结果的研究。提取并分类了提供的定义,并进行了比较分析。
59 项研究符合纳入标准,共纳入 14368 例患者和 18920 例乳房。34 项研究(57.6%)仅根据总乳房报告皮瓣坏死,11 项研究(18.6%)仅根据总患者报告皮瓣坏死。只有 14 项研究(23.7%)提供了两种独立的发生率。当按乳房或患者分别报告时,乳房皮瓣坏死的总体发生率为 10.4%(范围为 2.3%至 41.2%)和 15.3%(范围为 4.7%至 39.0%)。研究按皮瓣坏死的定义进行分类,包括干预(n=33)、深度(n=20)、面积(n=4)和时间(n=2)。按深度定义坏死的研究中皮瓣坏死率最高(15.1%),其次是干预(9.6%)、时间(6.4%)和面积(6.3%)。干预、深度和面积定义的皮瓣坏死发生率在统计学上存在显著差异(p<0.001)。
现有文献中,报告的乳房皮瓣坏死定义和结果差异很大。为了准确描述和量化,必须采用明确、简化的共识定义。